Literature DB >> 21332096

Cancer: PDE11a—a phenotype modifier in carney complex.

Linda Koch.   

Abstract

Entities:  

Year:  2011        PMID： 21332096     DOI： 10.1038/nrendo.2010.225

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.

Authors:  Rossella Libé; Anelia Horvath; Delphine Vezzosi; Amato Fratticci; Joel Coste; Karine Perlemoine; Bruno Ragazzon; Marine Guillaud-Bataille; Lionel Groussin; Eric Clauser; Marie-Laure Raffin-Sanson; Jennifer Siegel; Jason Moran; Limor Drori-Herishanu; Fabio Rueda Faucz; Maya Lodish; Maria Nesterova; Xavier Bertagna; Jerome Bertherat; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2010-11-03       Impact factor: 5.958
  1 in total
  2 in total

1.  Phosphodiesterase 11 A (PDE11A), a potential biomarker for glioblastoma.

Authors:  Hyunji Lee; Sungjin Park; Gyeyeong Kong; So Hee Kwon; Jisoo Park; Jongsun Park; Seon-Hwan Kim
Journal:  Toxicol Res       Date:  2022-04-12

2.  An epigenome-wide DNA methylation study of patients with COVID-19.

Authors:  Shengyu Zhou; Jintao Zhang; Jiawei Xu; Fayan Zhang; Peng Li; Yujie He; Julong Wu; Chunting Wang; Ximing Wang; Wei Zhang; Kang Ning; Yun Pan; Tian Liu; Jiping Zhao; Lixia Yin; Rumin Zhang; Feng Gao; Jintong Zhao; Liang Dong
Journal:  Ann Hum Genet       Date:  2021-06-29       Impact factor: 2.180
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.